Biotech Week articles from September 2003

Biotech Week archives from September 2003

Preliminary results of phase III PRIMO-CABG trial reported.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced preliminary results of its phase III study in a large, multinational trial consisting of more than 3,000 patients undergoing coronary artery bypass graft...

Hepatitis vaccines: Recent advances.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- According to recent research published in the International Journal for Parasitology, "Despite the availability of hepatitis A vaccines that might provide protection for decades, hepatitis B vaccines...

Trial tests treatment for postmenopausal cancer patients who relapse.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that patient recruitment has begun on an important new trial involving its novel estrogen receptor antagonist, "Faslodex" (fulvestrant). The trial, called EFECT, is designed...

FDA gives green light to U.S. phase I clinical trials for Psoraxine.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Astralis, Ltd., (ASTR) announced that the U.S. Food and Drug Administration (FDA) has allowed the company to start phase I clinical trials in the U.S. for Psoraxine for the treatment of moderate to...

Clinical trial: Squalamine improves vision in wet AMD.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) announced strong clinical results, including improved vision, for the phase I/II clinical trial of its systemically administered antiangiogenic drug, squalamine, for the treatment...

Labeling changes required for drug products that contain salmeterol.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) is announcing the addition of new safety information and warnings to the labeling for drug products that contain salmeterol, a long-acting bronchodilator used...

Allosteric activators of glucokinase show promise for diabetes therapy.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Allosteric activators of glucokinase show promise as treatments for diabetes. "Glucokinase (GK) plays a key role in whole-body glucose homeostasis by catalyzing the phosphorylation of glucose in...

Interleukin-21 gene therapy activates perforin-dependent tumor immunity.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Interleukin-21 gene therapy activates perforin-dependent tumor immunity. According to recent research from the United States, "Interleukin (IL)-21 is a key factor in the transition between innate...

APF112 phase II submitted for FDA review; royalty income increases 11%.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended June 30, 2003, reflecting increased royalty income and contract revenues as well as higher research and development expenses...

Report tells older Americans how to fight sleeplessness.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The sleeplessness affecting about one-third of all older Americans is not a natural part of aging and can lead to serious health disorders, according to Getting Your ZZZZZZZs: How Sleep Affects Health...

Heart valve company raises $12.3M in private placement of common stock.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Michael D. Dale, president and CEO of ATS Medical, Inc., (ATSI) announced the execution of agreements to sell 4.4 million shares of common stock for gross proceeds of $12.3 million in a private...

Clinical trial cleared for NeuGene against virus; financial results reported.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII, AVIIW, AVIIZ) announced that it has satisfied all regulatory requirements for initiating a multicenter phase Ib clinical trial with its NeuGene drug AVI-4020 in patients...

Blue Cross unit decides to fully cover drug that prolongs patient survival.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A South Carolina Medicare claims company has decided to pay more for a drug that helps dialysis patients live longer. The change is effective immediately. A recent New England Journal of Medicine...

Research alliance centers on monoclonal antibody for inflammatory disease.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories and LigoCyte Pharmaceuticals, Inc., announced a research collaboration on an anti-inflammatory monoclonal antibody for the treatment of inflammatory diseases. The collaboration...

Phase I clinical testing of ACP-103 complete.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals has successfully completed phase I clinical testing of ACP-103, the company's proprietary small molecule 5-HT2A inverse agonist. The study was designed to evaluate the...

Series B financing raises $26.4M to fund infectious disease program.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- ActivBiotics, Inc., announced an initial closing of $26.4 million on its Series B round of financing. MDS Capital Corp. led the funding round that included other new investors BioVentures...

Alliance to deliver electronic clinical trial solution.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Acumen Healthcare Solutions, LLC, said the company has partnered with Agiliti, Inc. By providing a robust, centralized information technology infrastructure, Agiliti enables Acumen to provide...

Biotech company reports $0.36 per share loss.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) reported financial results for the 3- and 6-month periods ended June 30, 2003. For the 3 months ended June 30, 2003, the company reported a net loss of $11.5 million or...

Patent pending for antibodies to treat solid organ, cell transplant rejection.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Advanced Biotherapy, Inc., (ADVB) announced that it has a patent application pending for the use of antibodies to gamma interferon (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) and both...

Pulsatile drug company files with SEC for IPO.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corporation announced that it filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering (IPO) of its common stock....

BlockAide trial to begin in fourth quarter; scientific advisory board formed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (AVRX) announced the formation of its new scientific advisory board, consisting of three well-known academic experts in the areas of anticancer and antiviral development....

Oncology drug maker reports 66% increase in revenue.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Aeterna Laboratories, Inc., (AEL; AELA) reported total revenues for the second quarter ended June 30, 2003, of $38.9 million, an increase of 66% compared with total revenues of $23.4 million for the...

New method available for detecting toxic mold.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Atlanta, Georgia-based indoor air quality company, Air Quality Sciences, Inc., (AQS), is offering a new analysis to test for Stachybotrys chartarum, often referred to as toxic mold, in a fungal sample....

Dialysis company reports net loss of $0.19 per share.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the quarter ended June 30, 2003. For the second quarter of 2003, Aksys reported total revenues of $301,000 compared to no revenue for the second quarter of...

Nasal vaccine may increase protection.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A vaccine administered through the nasal passages may increase protection against pneumococcal disease compared to the current vaccine, say researchers from Albany Medical College in New York and the...

Grants to fund rapid, portable detection systems for HIV, blood lead.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Alderon Biosciences of Research Triangle Park, North Carolina, announced the award of two new research grants. As the original developer and manufacturer of the LeadCare, a U.S. Food and Drug...

Causes of lower-extremity bowing must be distinguished for proper management.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Causes of lower-extremity bowing must be distinguished for proper management. According to recent research from the United States, "lower-extremity bowing is common in infants and children and can...

Drug delivery company reports $0.47 per share loss.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended June 30, 2003. The net loss on a GAAP basis for the quarter ended June 30, 2003, was $30.6 million or $0.47 per...

Novel genetic hemophilia markers improve prenatal diagnosis.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A series of novel genetic markers may improve prenatal hemophilia development. "The heterogeneous nature of the mutations, the size, and the complexity of the factor VIII gene makes direct mutation...

First component of rolling NDA submitted for RSR13.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has begun submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the company's investigational radiation...

First Flexogan order delivered to Canadian retailer.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- AlphaRx, Inc., (ALRX) announced their first product delivery. Flexogan, AlphaRx's topical pain reliever, has been delivered to Loblaw Companies Limited, a mass market retailer in Canada. Flexogan,...

Study finds limited benefit from two oral drugs.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- An 18-month pilot study of two commonly available treatments has shown no significant benefit in patients with interstitial cystitis (IC). The results are reported in the September 2003 issue of the...

Breast, prostate cancers focus of new Cancer Society research professorships.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The American Cancer Society has awarded its latest clinical research professorships to two scientists who are studying the translation of basic biology to the treatment of cancer. The two...

Disaster relief fund in jeopardy.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Over the past year, the American Red Cross spent $114.3 million from its Disaster Relief Fund to provide assistance to victims of more than 3,300 disasters throughout the United States and its...

Stroke group announces new program in Dallas.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The American Stroke Association, a division of the American Heart Association, and the Dallas County Medical Society announced the Dallas Area Stroke Network, a voluntary collaboration between hospitals...

First of three phase III exenatide studies achieves positive results.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) and Eli Lilly and Co. (LLY) announced that exenatide (synthetic exendin-4) produced statistically significant, dose-dependent reductions in the primary glucose...

Biotherapeutics company reports loss of $0.24 per share.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Applied Molecular Evolution, Inc., (AME, AMEV) reported financial results for the second quarter of 2003. For the quarter ended June 30, 2003, the company reported a net loss of $5.0 million or...

Drug discovery firm meets analysts' estimate for revenues, earnings.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the fourth quarter and full year of fiscal 2003, ended June 30, 2003. During the fourth quarter of fiscal 2003, Array reported total...

Device company reports 129% increase in net income.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Arrhythmia Research Technology, Inc., (HRT) and it's wholly owned subsidiary Micron Products, Inc., (Micron) reported total revenue of $1,940,000 and net income of $285,000 for the second quarter of...

Factors influencing choice of prenatal genetic screening by Israeli women identified.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Factors influencing Israeli women's decisions to undergo prenatal genetic screening have been identified. "The number of prenatal genetic tests that are being offered to women is constantly...

FDA approves new therapy.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Crestor (rosuvastatin) to lower cholesterol. Rosuvastatin is in the class of drugs called HMG-CoA reductase inhibitors, also known as...

Ximelagatran is safe given twice daily in a fixed dose regimen.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Ximelagatran is safe given twice daily in a fixed dose regimen. "Ximelagatran (Exanta, AstraZeneca) is a novel, oral direct thrombin inhibitor (oral DTI) that is rapidly converted to melagatran,...

HIV-1-infected children have impaired immunological memory.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- HIV-infected children who were immunized with "Haemophilus influenzae vaccine exhibited impaired immunological memory. According to a study from Greece, "Haemophilus influenzae type b (Hib)...

Patient enrollment completed in phase IIb CART-2 study with AGI-1067.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) has recently completed enrollment in a phase IIb clinical trial evaluating its proprietary v-protectant drug candidate, AGI-1067, as a treatment for atherosclerosis and...

Doctors Laboratory to offer VAP expanded cholesterol test.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Doctors Laboratory, Inc., will offer the next-generation VAP (Vertical Auto Profile) Cholesterol Test as part of its expansive menu of diagnostic services. The VAP Test, developed by Birmingham,...

Pharmaceutical company reports net loss of $0.01 per share.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- AutoImmune, Inc., (AIMM) reported a net loss of $0.14 million, or $0.01 per share basic and diluted, for the 3 months ended June 30, 2003, compared with a net loss of $0.18 million, or $0.01 per share...

Agreement signed for use of chemical assay.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Avitar, Inc., (AVR) announced that it has signed a Letter of Understanding with Immunomatrix, Inc., for the exclusive right to utilize Immunomatrix's high sensitivity chemical assay technologies in...

FDA approves Photofrin for the ablation of high-grade dysplasia.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced that it has received approval from the U.S Food and Drug Administration (FDA) for the use of Photofrin photodynamic therapy (PDT) in the ablation of high-grade dysplasia...

Thalidomide has been found to be effective for relapsed or refractory myeloma.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Thalidomide has been found to be effective for relapsed or refractory myeloma. "Since new treatments have recently been proposed for patients with multiple myeloma, the aim of this article is to...

Company's system helps reduce medication errors.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- B. Braun Medical, Inc., announced the launch of a new high speed production line in Irvine, California, to meet the growing customer demand for the Duplex Drug Delivery System, a new system designed to...

Pharmaceutical firm reports earnings of $2.43 per share.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) reported revenues of $902.9 million and net earnings of $167.6 million, or $2.43 per fully diluted share for its fiscal year ended June 30, 2003, which included charges of...

Inactivated parapoxvirus ovis protects against hepatitis and herpes viruses.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Inactivated parapoxvirus ovis protects against hepatitis and herpes viruses. "It is known that some viruses are able to induce vigorous immune reactions. This study shows that inactivated...

Targeted DNA vaccine may reverse disease.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Stanford University Medical Center researchers have developed a way to tailor therapies to combat the specific inappropriate responses of autoimmune diseases in mice. The researchers also have shown...

Hepatitis C virus patients often form elevated serum lipase levels.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus patients often form elevated serum lipase levels. "Extrahepatic manifestations of chronic hepatitis C virus (HCV) infection have been well described. However, hyperlipasemia and/or...

Novel HIV-based cDNA cloning system may aid genetic research.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A novel HIV-based cDNA cloning system may aid genetic research. "Expression cloning of cDNAs is a powerful tool with which to identify genes based on their specific functional properties,"...

Substance P expression linked to diarrhea severity during cryptosporidiosis.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Substance P (SP) expression is linked to diarrhea severity in cryptosporidiosis patients. "Cryptosporidiosis, caused by Cryptosporidium parvum, is self-limited in immunocompetent hosts but may cause...

InnaPhase finalizes acquisition of laboratory automation operations.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- InnaPhase Corp., a privately owned software company and provider of laboratory information management systems (LIMS) solutions for the life-sciences market, announced that it has closed the transaction...

Drug information available in handheld database.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Beiks LLC has released the MedicineNet Pocket Drug Guide, a new handheld version of MedicineNet, Inc.'s doctor-produced informational database of 400-plus monographs covering more than 1,000 generic and...

User-defined assays may have applicability in management of leukemia.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- User-defined assays may have applicability in management of leukemia. "An increasing number of risk-stratifying genetic lesions in acute leukemia are being discovered and characterized," scientists...

FDA license granted for new HIV test kit.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO, BIO.B) has received a license from the U.S. Food and Drug Administration for its HIV-1/HIV-2 PLUS O EIA test kit used for diagnostic testing and the screening of blood...

Pharmaceutical firm reports loss of $0.14 per share.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced financial results for its second quarter ended June 30, 2003. The net loss was $9.1 million ($0.14 per share) for the second quarter of 2003 compared...

Hormone therapy company raises $10.3M in private placement.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has raised $10.3 million through the private placement of approximately 4.8 million newly issued shares of BioSante common stock to several new...

Biotech firm reports conditional continued listing on NASDAQ SmallCap.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- BioSpecifics Technologies Corp. (BSTCE) has been notified by The NASDAQ Stock Market that the NASDAQ Listing Qualifications Panel has determined to continue the listing of the company's common stock on...

Status of stock offering reported by laser company.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI) announced that it and its independent accountants have decided to seek guidance from the U.S. Securities and Exchange Commission (SEC) regarding the accounting affect of...

RABBIT trial started to evaluate b-type natriuretic peptide.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE) announced the start of the RABBIT (Rapid Assessment of Bedside BNP in Treatment of congestive heart failure) clinical trial, which is designed to evaluate measurements of...

Novel less-sensitive EIA may improve HIV infection tracking.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A novel immunoassay may improve epidemiological tracking of HIV infection. "The sensitive/less-sensitive (S/LS) enzyme immunoassay (EIA) testing strategy for discriminating 'early' from...

Body monitoring device company raises $4M.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- BodyMedia announced the closing of a $4 million series C preferred stock financing round. The round was led by Draper Fisher Jurvertson ePlanet and Draper Triangle Ventures; Saturn Partners and the...

Bone marrow derived cells could heal organs through wound entry.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Bone marrow derived cells could heal organs through wound entry. "Bone marrow has long been known to be a source of stem cells capable of regeneration of the hematopoietic system. Recent reports,...

Up-regulation of elastin gene expression related to increase in transcription.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Up-regulation of pulmonary elastin gene expression is related to an increase in level of transcription. According to a study from the United States, "Previously we have shown that treatment of...

Rosacea drug maker increases guidance for 2003.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) released guidance for estimated net sales and earnings per share for the year 2003. These projections represent an increase over the previous guidance set on...

Deletion in endocytic receptor gene Endo180 impairs collagen uptake.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A targeted deletion in the endocytic receptor gene Endo180 resulted in a defect in collagen uptake. "The four members of the mannose receptor family (the mannose receptor, the M-type phospholipase...

Absolute lymphocyte count recovery at 30 d associated with CD34+ graft survival.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Transplant of related CD34+ grafts and limited T cell addback work well; best survival relates to absolute lymphocyte counts at 30 days post-transplant. According to published research from England,...

FDA pledging get-tough stance with drug over-promotion.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The U.S. government is ordering the maker of a popular anticholesterol drug to air corrections after overstating Pravachol's benefits in ads to both consumers and doctors - an unusually tough move that...

Pharmaceutical firm to help state AIDS programs.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced an agreement with the state-administered AIDS Drug Assistance Programs (ADAPs) to provide interim emergency relief to help address the funding crisis facing...

Fertility specialists back warnings on human reproductive cloning.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Human reproductive cloning is not ethically or practically acceptable, according to the British Fertility Society. The Society spoke out in support of an article in the August 2003 edition of Human...

Role of c-jun N-terminal kinase in Parkinson disease investigated.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The role of c-jun N-terminal kinase (JNK) in Parkinson's disease has been investigated. "Given the critical role that the c-Jun N-terminal kinase (JNK) pathway plays in regulating many of the...

InSight completes purchase of mobile imaging assets in eastern U.S.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- InSight Health Services Corp. (InSight), a national provider of diagnostic imaging services, announced one of its wholly owned subsidiaries has completed the purchase of the majority of assets of the...

Novel PGD strategy improves muscular dystrophy diagnosis.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A novel genetic assay provides improved detection of embryos destined to suffer from muscular dystrophy. Scientists in France "have developed a preimplantation genetic diagnosis (PGD) strategy for...

Macrophage migration inhibitory factor acts in septic shock, may be good target.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Since macrophage migration inhibitory factor is involved in signaling to do with septic shock, it may be a target for controlling septic shock in patients. According to recent research from...

PET equipment supplier comments on proposed APC rates for 2004.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- CTI Molecular Imaging, Inc., (CTMI), a provider of positron emission tomography (PET) equipment, molecular probes, and services, commented on the announcement by the U.S. Centers for Medicare and...

Treatment for peanut-induced anaphylaxis may soon involve anti-IgE.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- For most food anaphylaxis, the cure still involves epinephrine; for peanut allergies there are some new solutions being developed that include use of anti-IgE antibodies. According to recent...

Novel 1,3,4-trisubstituted pyrazole derivatives stifle tumor growth mechanisms.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Novel 1,3,4-trisubstituted pyrazole derivatives stifle tumor growth mechanisms. According to recent research published in the journal Chemical & Pharmaceutical Bulletin, "several...

Reduction in work force announced at lab-on-a-chip company.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced that it is reducing its work force by approximately 50 positions, or 9% of its total head count. The reduction is part of ongoing integration efforts...

Anderson joins scientific advisory board at cancer drug firm.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Callisto Pharmaceuticals, Inc., (CLSP) announced that Kenneth C. Anderson, director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute and professor of medicine at Harvard...